FINWIRES · TerminalLIVE
FINWIRES

Medipal Launches Tender Offer for Paltac

By

MediPal Holdings (TYO:7459) has launched a tender offer to acquire full ownership of Paltac (TYO:8283), aiming to make the company a wholly owned subsidiary, according to a Tuesday filing on the Tokyo Stock Exchange.

The offer price is set at 6,650 yen per share, with the purchase period running from May 12 to July 7. The deal does not include a maximum acquisition limit, but sets a minimum threshold of 8.68 million shares to proceed.

Medipal, which already holds about 52.4% of Paltac, said the transaction is intended to consolidate ownership and strengthen group-wide distribution capabilities across pharmaceuticals, cosmetics and daily goods.

Paltac's board has expressed support for the offer and recommended that shareholders tender their shares.

If completed, Medipal plans to carry out a squeeze-out process to acquire the remaining shares and delist Paltac, making it fully owned by the group. The company said it intends to finance the transaction through bank loans.

Related Articles

Asia

Shandong Yisheng Livestock & Poultry Breeding's Broiler Chick, Pig Sales Rise in April

Shandong Yisheng Livestock & Poultry Breeding's (SHE:002458) broiler chick sales revenue jumped 55% to 219 million yuan in April, according to a Tuesday filing with the Shenzhen bourse.Sales volume grew 13 to 55.3 million broiler chicks.Its Yisheng 909 mini broiler chicks saw sales revenue of 12.8 million yuan, up 104% year over year, while its sales volume jumped 19% to 8.2 million.Breeding pig sales revenue surged 325% to 40.4 million yuan while sales volume expanded 478% to 19,521 breeding pigs.

$SHE:002458
Asia

Trendlines, Controlling Shareholder to Invest Combined $1.4 Million in Portfolio Firms

Trendlines Group (SGX:42T) said its board approved a capital injection into portfolio companies Ceretrieve and Vensica Medical by controlling shareholder Librae Holdings.Shares of the agrifood and med-tech company were down over 1% in Tuesday's afternoon trade.Librae will invest around $850,000 in the units. Additionally, Trendlines will infuse a total of $550,000 to the portfolio firms, according to a Monday filing with the Singapore Exchange.The funding is aimed at supporting the ongoing operations of the portfolio companies and helping them achieve successful exits, the filing said.Ceretrieve develops neurointerventional devices, while Vensica Medical specializes in bladder-targeted therapies.

$SGX:42T
Asia

Galaxy Entertainment Revenue Rises 11% in Q1 2026

Galaxy Entertainment Group (HKG:0027) reported HK$12.4 billion in first quarter 2026 revenue, up 11% from HK$11.20 billion a year earlier, according to a Tuesday filing with the Hong Kong bourse.Revenue from the gaming business increased to HK$10.02 billion from HK$8.92 billion in the prior year. Non-gaming revenue stood at HK$1.71 billion, rising from HK$1.56 billion, while sales from construction materials fell to HK$666 million from HK$723 million, figures showed.

$HKG:0027